Home > Resources > Whitepapers > Investor Update October 2022

Chemical Technology

Investor Update October 2022

October 11, 2022

Completed to acquire additional stakes in Lotus
Pharmaceutical to be 37% and invest in Adalvo
60%. Profit contribution started in 2Q22

Spotlight

IMMUNE Pharmaceuticals Inc.

Immune Pharmaceuticals applies a personalized approach to treating and developing novel, highly-targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. Immune's lead product candidate, bertilimumab, is in clinical development for moderate-to-severe ulcerative colitis as well as for bullous pemphigoid, an orphan auto-immune dermatological condition. Other indications considered for development include atopic dermatitis, Crohn's disease, severe asthma and NASH (inflammatory liver disease). Immune recently expanded its portfolio in immuno-dermatology, topical nano-formulated Cyclosporine A for the treatment of psoriasis and atopic dermatitis. Immune's pipeline also includes NanomAbs®, antibody nano-conjugates, for the targeted delivery of chemotherapeutics. Immune's Pain pipeline including AmiKet™ are in a partnering process for further development and commercialization.

OTHER WHITEPAPERS

Green Chemistry and Contract Synthesis – a Contradiction?

whitePaper | June 17, 2021

The topic of green chemistry is now also a challenge for contract synthesis suppliers. This is because more and more manufacturers of shampoos, detergents, paints, packaging and other consumer products are becoming increasingly concerned about the ecological footprint of their products. The trend is being fueled by consumers, who are increasingly prepared to spend more money on products that are better for the environment. But the political environment is also exerting major pressure on companies.

The path to Net Zero for Eastern Europe

whitePaper | October 25, 2022

ICIS is the global source of Independent Commodity Intelligence Services. For 150 years, we have connected data, markets, and customers to create a comprehensive,

2022 chemical industry outlook

whitePaper | April 14, 2022

The US chemical industry has witnessed a strong recovery since the beginning of 2021, with demand increasing from the major end markets such as construction and health and safety.

Industrial Internet of Things for hazardous areas: potential for the optimisation of existing plants

whitePaper | February 11, 2020

Whether oil and gas, chemicals, pharmaceuticals, mining or food, the development of an Industrial Internet of Things (IIoT) in combination with algorithms and artificial intelligence, releases an enormous optimisation potential - also and especially for existing plants. New business models transform CAPEX into OPEX and reduce the financial risk. For this, however, the information chain consisting of individual IIoT modules must not only be stringent,

ADVANCED DEMAND FLEXIBILITY MANAGEMENT

whitePaper | June 22, 2022

California’s electricity system is undergoing rapid transformation on the pathway to 100% renewable power, with the expected high penetration of renewables, electrification of buildings and transportation, and deployment of behind-the-meter (BTM) distributed energy resources (DERs).

Optimizing Carbon Capture, Utilization and Storage to Meet Ambitious Sustainability Goals

whitePaper | October 5, 2022

The race to a zero carbon future is on. Global oil and gas, petrochemical and chemical companies alike have announced ambitious and broad carbon mitigation.